Plus Therapeutics logo

Plus Therapeutics Share Price Today

(NASDAQ: PSTV)

Plus Therapeutics share price is $0.35 & ₹30.44 as on 6 Mar 2025, 2.30 'hrs' IST

$0.35

0.05

(15.82%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Plus Therapeutics share price in Dollar and Rupees. Guide to invest in Plus Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Plus Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Plus Therapeutics share price movements

  • Today's Low: $0.32
    Today's High: $0.37

    Day's Volatility :15.44%

  • 52 Weeks Low: $0.24
    52 Weeks High: $2.67

    52 Weeks Volatility :91.01%

Plus Therapeutics (PSTV) Returns

PeriodPlus Therapeutics IncIndex (Russel 2000)
3 Months
-73.88%
0.0%
6 Months
-74.55%
0.0%
1 Year
-81.91%
0.0%
3 Years
-97.62%
-11.6%

Plus Therapeutics (PSTV) Key Statistics

in dollars & INR

Previous Close
$0.3022
Open
$0.33
Today's High
$0.3736
Today's Low
$0.3159
Market Capitalization
$1.8M
Today's Volume
$1.1M
52 Week High
$2.6702
52 Week Low
$0.24
Revenue TTM
$5.7M
EBITDA
$-14.0M
Earnings Per Share (EPS)
$-1.09
Profit Margin
-225.07%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-522.5%

How to invest in Plus Therapeutics Stock (PSTV) from India?

It is very easy for Indian residents to invest directly in Plus Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Plus Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Plus Therapeutics or PSTV on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Plus Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Plus Therapeutics shares which would translate to 2.485 fractional shares of Plus Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Plus Therapeutics, in just a few clicks!

Returns in Plus Therapeutics (PSTV) for Indian investors in Rupees

The Plus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Plus Therapeutics investment value today

Current value as on today

₹22,990

Returns

₹77,010

(-77.01%)

Returns from Plus Therapeutics Stock

₹81,959 (-81.96%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Plus Therapeutics (PSTV)

20%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Plus Therapeutics Stock from India on INDmoney has increased by 20% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Plus Therapeutics

  • AIGH Capital Management, LLC

    9.51%

  • Geode Capital Management, LLC

    0.99%

  • Vanguard Group Inc

    0.55%

  • TWO SIGMA SECURITIES, LLC

    0.25%

  • BlackRock Inc

    0.12%

  • Tower Research Capital LLC

    0.08%

Analyst Recommendation on Plus Therapeutics

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Plus Therapeutics(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Plus Therapeutics Stock (PSTV)

What analysts predicted

Upside of 4400.0%

Target:

$15.75

Current:

$0.35

Insights on Plus Therapeutics Stock (Ticker Symbol: PSTV)

  • Price Movement

    In the last 7 days, PSTV stock has moved down by -48.1%
  • Decreasing Revenue

    Revenue is down for the last 2 quarters, 1.67M → 1.27M (in $), with an average decrease of 23.7% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 4 quarters, -3.81M → -2.87M (in $), with an average increase of 10.0% per quarter
  • PSTV vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 148.4%
  • PSTV vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 149.3%
  • Price to Sales

    ForPSTV every $1 of sales, investors are willing to pay $0.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Plus Therapeutics Technicals Summary

Sell

Neutral

Buy

Plus Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Plus Therapeutics (PSTV) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Plus Therapeutics Inc logo
-72.0%
-74.55%
-81.91%
-97.62%
-98.66%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Plus Therapeutics Inc logo
NA
NA
NA
-2.06
-5.22
-0.9
NA
-0.88
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Plus Therapeutics Inc logo
Buy
$1.8M
-98.66%
NA
-225.07%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Plus Therapeutics

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.
Organization
Plus Therapeutics
Employees
20
CEO
Dr. Marc H. Hedrick M.B.A., M.D.
Industry
Health Technology

Management People of Plus Therapeutics

NameTitle
Dr. Marc H. Hedrick M.B.A., M.D.
President, CEO & Director
Mr. Andrew J. Sims CPA
VP of Finance & CFO
Dr. Michael Stanley Rosol Ph.D.
Chief Development Officer
Ms. Desiree Smith
Corporate Controller

Important FAQs about investing in PSTV Stock from India :

What is Plus Therapeutics share price today?

Plus Therapeutics share price today stands at $0.35, Open: $0.33 ; Previous Close: $0.30 ; High: $0.37 ; Low: $0.32 ; 52 Week High: $2.67 ; 52 Week Low: $0.24.

The stock opens at $0.33, after a previous close of $0.30. The stock reached a daily high of $0.37 and a low of $0.32, with a 52-week high of $2.67 and a 52-week low of $0.24.

Can Indians buy Plus Therapeutics shares?

Yes, Indians can invest in the Plus Therapeutics (PSTV) from India.

With INDmoney, you can buy Plus Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Plus Therapeutics at zero transaction cost.

How can I buy Plus Therapeutics shares from India?

It is very easy to buy Plus Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Plus Therapeutics (PSTV) be purchased?

Yes, you can buy fractional shares of Plus Therapeutics with INDmoney app.

What are the documents required to start investing in Plus Therapeutics stocks?

To start investing in Plus Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Plus Therapeutics Stock (PSTV)?

Today’s highest price of Plus Therapeutics (PSTV) is $0.37.

Today’s lowest price of Plus Therapeutics (PSTV) is $0.32.

What is today's market capitalisation of Plus Therapeutics?

Today's market capitalisation of Plus Therapeutics PSTV is 1.8M

What is the 52 Week High and Low Range of Plus Therapeutics Stock (PSTV)?

  • 52 Week High

    $2.67

  • 52 Week Low

    $0.24

What are the historical returns of Plus Therapeutics (PSTV)?

  • 1 Month Returns

    -72%

  • 3 Months Returns

    -74.55%

  • 1 Year Returns

    -81.91%

  • 5 Years Returns

    -98.66%

Who is the Chief Executive Officer (CEO) of Plus Therapeutics ?

Dr. Marc H. Hedrick M.B.A., M.D. is the current Chief Executive Officer (CEO) of Plus Therapeutics.